|
Item
1.
|
Financial
Statements.
|
SanSal
Wellness Holdings, Inc. and Subsidiary
Consolidated
Balance Sheets
(Unaudited)
|
|
|
|
|
|
|
|
|
September
30,
|
|
|
December
31,
|
|
ASSETS
|
|
2017
|
|
|
2016
|
|
CURRENT ASSETS
|
|
|
|
|
|
|
|
|
Cash
and Cash Equivalents
|
|
$
|
95,255
|
|
|
$
|
95,591
|
|
Inventories
|
|
|
1,587,271
|
|
|
|
659,048
|
|
Prepaid
Expenses
|
|
|
3,915
|
|
|
|
—
|
|
Total
Current Assets
|
|
$
|
1,686,441
|
|
|
$
|
754,639
|
|
|
|
|
|
|
|
|
|
|
PROPERTY
PLANT AND EQUIPMENT, net of accumulated depreciation of $222,151 and $73,318, respectively
|
|
$
|
4,438,483
|
|
|
$
|
4,213,429
|
|
|
|
|
|
|
|
|
|
|
OTHER ASSETS
|
|
|
|
|
|
|
|
|
Land
- held for investment
|
|
$
|
—
|
|
|
$
|
69,000
|
|
Deposits
|
|
|
23,000
|
|
|
|
—
|
|
Total
Other Assets
|
|
$
|
23,000
|
|
|
$
|
69,000
|
|
|
|
|
|
|
|
|
|
|
TOTAL
ASSETS
|
|
$
|
6,147,924
|
|
|
$
|
5,037,
068
|
|
See
Accompanying Notes to Consolidated Financial Statements (Unaudited)
|
|
September
30,
|
|
|
December
31,
|
|
|
|
2017
|
|
|
2016
|
|
LIABILITIES
AND STOCKHOLDERS’ EQUITY
|
|
|
|
|
|
|
|
|
CURRENT LIABILITIES
|
|
|
|
|
|
|
|
|
Accounts
Payable
|
|
$
|
156,182
|
|
|
$
|
13,828
|
|
Accrued Expenses
|
|
|
200,000
|
|
|
|
6,756
|
|
Accrued Interest
|
|
|
21,037
|
|
|
|
—
|
|
Accrued Interest -
Stockholders
|
|
|
9,716
|
|
|
|
—
|
|
Notes Payable to Stockholders
|
|
|
1,030,080
|
|
|
|
—
|
|
Current Portion of
Long Term Debt
|
|
|
395,416
|
|
|
|
390,600
|
|
Total Current Liabilities
|
|
$
|
1,812,431
|
|
|
$
|
411,184
|
|
|
|
|
|
|
|
|
|
|
LONG-TERM DEBT
|
|
$
|
255,283
|
|
|
$
|
323,406
|
|
|
|
|
|
|
|
|
|
|
STOCKHOLDERS’ EQUITY
|
|
|
|
|
|
|
|
|
Common
Stock, $0.001 par value, 200,000,000 shares authorized, 60,540,000 and 58,500,000 shares issued and outstanding at
September 30, 2017 and December 31, 2016, respectively
|
|
$
|
60,540
|
|
|
$
|
58,500
|
|
Additional Paid in
Capital
|
|
|
6,592,574
|
|
|
|
5,730,738
|
|
Retained Earnings (Deficit)
|
|
|
(2,572,904
|
)
|
|
|
(1,486,760
|
)
|
Total Stockholders’
Equity
|
|
$
|
4,080,210
|
|
|
$
|
4,302,478
|
|
|
|
|
|
|
|
|
|
|
TOTAL LIABILITIES AND
STOCKHOLDERS’ EQUITY
|
|
$
|
6,147,924
|
|
|
$
|
5,037,068
|
|
See
Accompanying Notes to Consolidated Financial Statements (Unaudited)
SanSal
Wellness Holdings, Inc. and Subsidiary
Consolidated
Statements of Operations
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30,
|
|
|
Nine Months Ended September 30,
|
|
|
|
2017
|
|
|
2016
|
|
|
2017
|
|
|
2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales
|
|
$
|
255,444
|
|
|
$
|
—
|
|
|
$
|
755,749
|
|
|
$
|
11,773
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of sales
|
|
|
116,726
|
|
|
|
—
|
|
|
|
367,328
|
|
|
|
9,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
$
|
138,718
|
|
|
$
|
—
|
|
|
$
|
388,421
|
|
|
$
|
2,273
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating Expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, General and Administrative
|
|
$
|
279,443
|
|
|
$
|
457,801
|
|
|
$
|
1,070,637
|
|
|
$
|
749,453
|
|
Total Operating Expenses
|
|
$
|
279,443
|
|
|
$
|
457,801
|
|
|
$
|
1,070,637
|
|
|
$
|
749,453
|
|
Operating loss
|
|
$
|
(140,725
|
)
|
|
$
|
(457,801
|
)
|
|
$
|
(682,216
|
)
|
|
$
|
(747,180
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Income (Expense)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Merger Expenses
|
|
$
|
(260,750
|
)
|
|
$
|
—
|
|
|
$
|
(260,750
|
)
|
|
$
|
—
|
|
Interest Expense - Related Party
|
|
|
(6,092
|
)
|
|
|
—
|
|
|
|
(9,716
|
)
|
|
|
—
|
|
Interest Expense - Other
|
|
|
(5,800
|
)
|
|
|
—
|
|
|
|
(21,037
|
)
|
|
|
—
|
|
Total Other Income (Expense)
|
|
|
(272,642
|
)
|
|
|
—
|
|
|
|
(291,503
|
)
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss before Income Taxes
|
|
$
|
(413,367
|
)
|
|
$
|
(457,801
|
)
|
|
$
|
(973,719
|
)
|
|
$
|
(747,180
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income Tax Provision
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NET LOSS
|
|
$
|
(413,367
|
)
|
|
$
|
(457,801
|
)
|
|
$
|
(973,719
|
)
|
|
$
|
(747,180
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Loss per Share
|
|
$
|
(0.01
|
)
|
|
$
|
(0.01
|
)
|
|
$
|
(0.02
|
)
|
|
$
|
(0.01
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted Average Shares Outstanding
|
|
|
58,567,253
|
|
|
|
58,500,000
|
|
|
|
58,522,500
|
|
|
|
58,500,000
|
|
See
Accompanying Notes to Consolidated Financial Statements (Unaudited)
SanSal
Wellness Holdings, Inc. and Subsidiary
Consolidated
Statements of Cash Flows
(Unaudited)
|
|
Nine Months Ended September 30,
|
|
|
|
2017
|
|
|
2016
|
|
CASH FLOWS FROM OPERATING ACTIVITIES
|
|
|
|
|
|
|
|
|
Net Loss
|
|
$
|
(973,719
|
)
|
|
$
|
(747,180
|
)
|
Adjustments to Reconcile Net Loss to Net Cash
|
|
|
|
|
|
|
|
|
Used Operating Activities
|
|
|
|
|
|
|
|
|
Depreciation
|
|
|
148,833
|
|
|
|
53,980
|
|
Stock-based Compensation
|
|
|
198,476
|
|
|
|
—
|
|
Changes in Operating Assets and Liabilities
|
|
|
|
|
|
|
|
|
Inventories
|
|
|
(1,040,648
|
)
|
|
|
(732,722
|
)
|
Prepaid Expenses
|
|
|
(3,915
|
)
|
|
|
18,238
|
|
Deposits
|
|
|
(23,000
|
)
|
|
|
(10,003
|
)
|
Accounts Payable and Other Current Liabilities
|
|
|
366,351
|
|
|
|
45,067
|
|
|
|
|
|
|
|
|
|
|
NET CASH USED IN OPERATING ACTIVITIES
|
|
$
|
(1,327,622
|
)
|
|
$
|
(1,372,620
|
)
|
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM INVESTING ACTIVITIES
|
|
|
|
|
|
|
|
|
Purchase of Property and Equipment
|
|
|
(373,887
|
)
|
|
|
(2,214,832
|
)
|
|
|
|
|
|
|
|
|
|
NET CASH USED IN INVESTING ACTIVITIES
|
|
$
|
(373,887
|
)
|
|
$
|
(2,214,832
|
)
|
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM FINANCING ACTIVITIES
|
|
|
|
|
|
|
|
|
Payment for Capital Lease
|
|
|
—
|
|
|
|
(215,606
|
)
|
Payments of Long-term Debt
|
|
$
|
(12,704
|
)
|
|
$
|
(10,204
|
)
|
Proceeds from Note Payable Stockholders
|
|
|
1,030,080
|
|
|
|
—
|
|
Payments on Advance to Stockholders
|
|
|
—
|
|
|
|
(157,981
|
)
|
Proceeds from Issuance of Common Stock
|
|
|
150,030
|
|
|
|
—
|
|
Proceeds from Additional Paid in Capital from Shareholders
|
|
|
533,767
|
|
|
|
4,005,525
|
|
NET CASH PROVIDED BY FINANCING ACTIVITIES
|
|
$
|
1,701,173
|
|
|
$
|
3,621,734
|
|
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS
|
|
$
|
(336
|
)
|
|
$
|
34,282
|
|
CASH AND CASH EQUIVALENTS - Beginning of Period
|
|
|
95,591
|
|
|
|
17,788
|
|
|
|
|
|
|
|
|
|
|
CASH AND CASH EQUIVALENTS - End of Period
|
|
$
|
95,255
|
|
|
$
|
52,070
|
|
See
Accompanying Notes to Consolidated Financial Statements (Unaudited)
SanSal
Wellness Holdings, Inc. and Subsidiary
Notes
to Consolidated Financial Statements
(Unaudited)
NOTE
1: NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Nature
of Business
SanSal
Wellness Holdings Inc. (formerly Armeau Brands Inc.), (the “Company”), was incorporated in the State of Nevada on
March 15, 2011. The Company’s business objectives are to produce natural rich-hemp products, using strict natural protocols
and materials yielding broad spectrum phytocannabinoid rich hemp oils, distillates and isolates. The Company is licensed by the
Colorado Department of Agriculture to grow industrial hemp pursuant to Federal law on its farm.
Effective
September 27, 2017, the Company acquired 100% of the issued and outstanding limited liability company membership interests of
271 Lake Davis Holdings LLC dba SanSal Wellness (“271 Lake Davis”) in exchange for 7,800,000 restricted shares of
the Company’s common stock, which represented 100% of 271 Lake Davis’s total member units outstanding immediately
following the closing of the transaction. The transaction has been accounted for as a reverse merger, whereby 271 Lake Davis is
the accounting survivor and the historical financial statements presented are those of 271 Lake Davis. On October 13, 2017, the
Company filed Amended and Restated Articles of Incorporation with the Nevada Secretary of State changing the name from “Armeau
Brands Inc.” to “SanSal Wellness Holdings, Inc.”
Sansal,
LLC was a wholly owned subsidiary that was merged into 271 Lake Davis Holdings, LLC in January 2016.
Going Concern
The accompanying financial statements
have been prepared in conformity with accounting principles generally accepted in the United States, which contemplate continuation
of the Company as a going concern. However, the Company has sustained substantial losses from operations since its inception.
As of September 30, 2017, the Company had an accumulated deficit of $2,572,904 and a working capital deficit of $125,990. These
factors, among others, raise substantial doubt about the ability of the Company to continue as a going concern Our continuation
as a going concern is dependent on our ability to raise additional capital and financing, though there is no assurance we will
be successful in our efforts.
Basis
of Presentation
The
accompanying unaudited financial statements have been prepared in accordance with accounting principles generally accepted in
the United States of America for interim financial statements and with the instructions to Form 10-Q and Article 8 of Regulation
S-X of the United States Securities and Exchange Commission (the “SEC”). Accordingly, they do not contain all information
and footnotes required by accounting principles generally accepted in the United States of America for annual financial statements.
In the opinion of the Company’s management, the accompanying unaudited financial statements contain all the adjustments
necessary (consisting only of normal recurring accruals) to present the financial position of the Company as of September 30,
2017, and the results of operations and cash flows for the periods presented. The results of operations for the three and nine
months ended September 30, 2017, are not necessarily indicative of the operating results for the full fiscal year or any future
period.
Principles
of Consolidation
The
accompanying consolidated financial statements reflect the accounts of Sansal Wellness Holdings, Inc. and 271 Lake Davis Holdings
and its wholly owned subsidiary, Sansal, LLC. All significant inter-company accounts and transactions have been eliminated in
consolidation.
Use
of Estimates
The
preparation of financial statements in conformity with accounting principles generally accepted in the United States of America
requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Actual results could
differ from these estimates.
NOTE
1: NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
Fair
Value Measurement
The
estimated fair values of the Company’s short-term financial instruments, including receivables and payables arising in the
ordinary course of business, approximate their individual carrying amounts due to the relatively short period of time between
their origination and expected realization.
Cash
and Cash Equivalents
The
Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. At times,
cash and cash equivalents may be in excess of FDIC insurance limits.
Revenue
Recognition
The
Company recognizes revenue in accordance with Accounting Standards Codification No. 605, “Revenue Recognition” (“ASC-605”),
ASC-605 requires that four basic criteria must be met before revenue can be recognized: (1) persuasive evidence of an arrangement
exists; (2) delivery has occurred; (3) the selling price is fixed and determinable; and (4) collectability is reasonably assured.
Determination of criteria (3) and (4) are based on management’s judgments regarding the fixed nature of the selling prices
of the products delivered and the collectability of those amounts. Provisions for discounts and rebates to customers, estimated
returns and allowances, and other adjustments are provided for in the same period the related sales are recorded. The Company
will defer any revenue for which the product or servicers has not been delivered or provided or is subject to refund until such
time that the Company and the customer jointly determine that the product has been delivered or no refund will be required.
Inventories
Inventories
consist of growing and processed plants and oils and are valued at the lower of cost or market. In evaluating whether inventories
are stated at lower of cost or market, management considers such factors as inventories in hand, estimated time to sell such inventories
and current market conditions. Write-offs for inventory obsolescence are recorded when, in the opinion of management, the value
of specific inventory items has been impaired.
Property
and Equipment
Purchase
of property and equipment are recorded at cost. Improvements and replacements of property and equipment are capitalized. Maintenance
and repairs that do not improve or extend the lives of property and equipment are charged to expense as incurred. When assets
are sold or retired, their cost and related accumulated depreciation are removed from the accounts and any gain or loss is reported
in the
Statements of Income
. Depreciation is provided over the estimated economic useful lives of each class of assets
and is computed using the straight-line method.
Estimated
economic useful lives of property and equipment range from 3 to 39 years.
NOTE
1: NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
Impairment
of Long-Lived Assets
The
carrying value of long-lived assets are reviewed when facts and circumstances suggest that the assets may be impaired or that
the amortization period may need to be changed. The Company considers internal and external factors relating to each asset, including
cash flows, local market developments, industry trends and other publicly available information. If these factors and the projected
undiscounted cash flows of the Company over the remaining amortization period indicate that the asset will not be recoverable,
the carrying value will be adjusted to the fair market value. No adjustment was considered necessary for the nine month period
ended September 30, 2017 and 2016, respectively.
Compensation
and Benefits
The
Company records compensation and benefits expense for all cash and deferred compensation, benefits, and related taxes as earned
by its employees. Compensation and benefits expense also includes compensation earned by temporary employees and contractors who
perform similar services to those performed by the Company’s employees.
Stock-Based
Compensation
Certain
employees, officers, directors, and consultants of the Company participate in various incentive plans that provide for granting
stock options and restricted stock awards. Stock options vest in equal increments over a three-year period and expire on the tenth
anniversary following the date of grant. Restricted stock awards vest 100% at the grant date.
The
Company recognizes stock-based compensation for equity awards granted to employees, officers, directors and consultants as compensation
and benefits expense in the consolidated statements of operations. The fair value of stock options is estimated using a Black-Scholes
valuation model on the date of grant. The fair value of restricted stock awards is equal to the closing price of the Company’s
stock on the date of grant. Stock-based compensation is recognized over the requisite service period of the individual awards,
which generally equals the vesting period.
The
Company recognizes stock-based compensation for equity awards granted to consultants as selling, general and administrative expense
in the consolidated statements of operations. The fair value of stock options is estimated using a Black-Scholes valuation model
on the date of grant and unvested awards are revalued at each reporting period. The fair value of restricted stock awards is equal
to the closing price of the Company’s stock on the date of grant multiplied by the number of shares awarded. Stock-based
compensation is recognized over the requisite service period of the individual awards, which generally equals the vesting period.
NOTE
1: NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
Income
Taxes
The
Company was a Limited Liability Company (“LLC”) for income tax purposes until September 27, 2017 when the reverse
merger took place as discussed in the “Nature of Business” footnote above. In lieu of corporate income taxes, the
owners were taxed on their proportionate shares of the Company’s taxable income. Accordingly, no liability for federal or
state income taxes and no provision for federal or state income taxes have been included in the financial statements.
In
accordance with Financial Accounting Standards Board ASC Topic 740, Income Taxes, management evaluated the Company’s tax
positions and concluded that the Company had taken no uncertain tax positions that require adjustment to the financial statements
to comply with the provisions of this guidance. The Company is subject to routine audits by taxing jurisdictions; however, there
are currently no audits for any tax periods in progress.
Effective
September 27, 2017 the Company was taxes as a C-Corporation. Income tax benefits are recognized for income tax positions taken
or expected to be taken in a tax return, only when it is determined that the income tax position will more-likely than-not be
sustained upon examination by taxing authorities. The Company has analyzed tax positions taken for filings with the Internal Revenue
Service and all tax jurisdictions where it operates. The Company believes that income tax filing positions will be sustained upon
examination and does not anticipate any adjustments that would result in a material adverse effect on the Company’s financial
condition, results of operations or cash flows. Accordingly, the Company has not recorded any reserves, or related accruals for
interest and penalties for uncertain income tax positions at September 30, 2017.
Related
Party Transactions
The
Company follows FASB ASC subtopic 850-10, Related Party Disclosures, for the identification of related parties and disclosure
of related party transactions. Pursuant to ASC 850-10-20, related parties include: a) affiliates of the Company; b) entities for
which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value
Option Subsection of Section 825–10–15, to be accounted for by the equity method by the investing entity; c) trusts
for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management;
d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party
controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting
parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence
the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties
and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully
pursuing its own separate interests.
NOTE
1: NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
Related
Party Transactions (Continued)
The
consolidated financial statements shall include disclosures of material related party transactions, other than compensation arrangements,
expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated
in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall
include: a) the nature of the relationship(s) involved; b) a description of the transactions, including transactions to which
no amounts or nominal amounts were ascribed, for each of the periods for which statements of operation are presented, and such
other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c) the
dollar amounts of transactions for each of the periods for which statements of operations are presented and the effects of any
change in the method of establishing the terms from that used in the preceding period; and d) amounts due from or to related parties
as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.
Subsequent
Events
The
Company has evaluated subsequent events through the date which the financial statements were available to be issued.
NOTE
2: INVENTORIES
Detail
of inventories are as follows:
|
|
September
30,
|
|
|
December
31,
|
|
|
|
2017
|
|
|
2016
|
|
Inventory
|
|
|
|
|
|
|
Finished
Goods
|
|
$
|
311,779
|
|
|
$
|
—
|
|
Work In Progress
|
|
|
1,275,492
|
|
|
|
546,623
|
|
Inventory
|
|
$
|
1,587,271
|
|
|
$
|
546,623
|
|
NOTE
3: PROPERTY AND EQUIPMENT
|
|
September
30,
|
|
|
December
31,
|
|
|
|
2017
|
|
|
2016
|
|
PROPERTY
AND EQUIPMENT
|
|
|
|
|
|
|
|
|
Land &
Land Improvements
|
|
$
|
398,126
|
|
|
$
|
364,825
|
|
Building and Improvements
|
|
|
1,437,806
|
|
|
|
1,427,130
|
|
Greenhouse
|
|
|
685,038
|
|
|
|
691,456
|
|
Machinery and Equipment
|
|
|
1,019,404
|
|
|
|
693,734
|
|
Furniture and Fixtures
|
|
|
267,900
|
|
|
|
257,242
|
|
Computer Equipment
|
|
|
21,019
|
|
|
|
21,019
|
|
Capital Lease Asset
|
|
|
815,180
|
|
|
|
815,180
|
|
Truck
|
|
|
16,161
|
|
|
|
16,161
|
|
|
|
$
|
4,660,634
|
|
|
$
|
4,286,747
|
|
Less Accumulated Depreciation
|
|
|
(222,151
|
)
|
|
|
(73,318
|
)
|
Property and Equipment
|
|
$
|
4,438,483
|
|
|
$
|
4,213,429
|
|
Total
depreciation expense was $49,611 and $17,944 for the 3 month period and $148,833 and $53,980 for the nine month period ended September
30, 2017 and 2016, respectively.
NOTE
4: LONG-TERM DEBT
Long-term
debt consisted of the following:
|
|
September
30,
|
|
|
December
31,
|
|
|
|
2017
|
|
|
2016
|
|
Note
Payable which requires monthly payments of $1,618 including interest at 6.00% per annum until February 1, 2020 when the
balance is due in full. The note is secured by specific assets of the Company.
|
|
$
|
112,445
|
|
|
$
|
125,149
|
|
|
|
|
|
|
|
|
|
|
Mortgage Payable which
requires monthly payments of $466 including interest at 6.00% per annum. The loan is secured by specific assets of the Company.
|
|
|
—
|
|
|
|
50,603
|
|
|
|
|
|
|
|
|
|
|
Capital Lease Payable
which requires monthly payments of $32,850 until May 2018, when the Company may purchase the equipment for $1.
|
|
|
538,254
|
|
|
|
538,254
|
|
|
|
|
|
|
|
|
|
|
|
|
|
650,699
|
|
|
|
714,006
|
|
Less Current Portion
|
|
|
(395,416
|
)
|
|
|
(390,600
|
)
|
Long-Term
Debt - net of current portion
|
|
$
|
255,283
|
|
|
$
|
323,406
|
|
Future
principal payments for the next 5 years are as follows for the years ended December 31:
2017
|
|
|
$
|
395,416
|
|
2018
|
|
|
$
|
181,670
|
|
2019
|
|
|
$
|
19,416
|
|
2020
|
|
|
$
|
54,197
|
|
|
|
|
$
|
650,699
|
|
NOTE
5: STOCK-BASED COMPENSATION
The
Company approved their 2017 Incentive Stock Plan on September 27, 2017 (the “Incentive Plan”) which authorizes the Company
to grant or issue non-qualified stock options, incentive stock options, stock appreciation rights, restricted stock, restricted
stock units and other equity awards up to a total of 1.250 million shares. The Company has not granted any stock appreciation
rights, restricted stock, restricted stock units or other equity options under the Incentive Plan. Under the terms of the Incentive
Plan, awards may be granted to our employees, directors or consultants. Awards issued under the Incentive Plan vest as determined
by the Board of Directors or any of the Committees appointed under the Incentive Plan at the time of grant.
The
Company’s outstanding stock options have a 10-year term. Outstanding non-qualified stock options granted to employees and
a consultant vested immediately. Outstanding incentive stock options issued to employees vest over a three-year period. The
incentive stock options granted vest based solely upon continued employment (“time-based”). The Company’s time-based
share awards that vest in their entirety at the end of three-year periods, time-based share awards where 33.3% of
the award vests on each of the three anniversary dates.
Stock-based
compensation expense was as follows:
|
|
Three
Months Ended
|
|
|
Nine
Months Ended
|
|
|
|
September
30:
|
|
|
September
30:
|
|
|
|
2017
|
|
|
2016
|
|
|
2017
|
|
|
2016
|
|
Non-Qualified
Stock Options - Immediate
|
|
$
|
198,476
|
|
|
$
|
—
|
|
|
$
|
198,476
|
|
|
$
|
—
|
|
Incentive
Stock Options - Time Bases
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
Total
Stock-based Copensation Expense
|
|
$
|
198,476
|
|
|
$
|
—
|
|
|
$
|
198,476
|
|
|
$
|
—
|
|
Stock
option activity was as follows in nine months ended September 30, 2017:
|
|
Stock
Options
|
|
|
Weighted-
Average
Exercise
|
|
|
Weighted-
Average
Remaining
|
|
Outstanding at Decmber 31, 2016
|
|
|
—
|
|
|
|
|
|
|
|
|
|
Granted
|
|
|
550,003
|
|
|
$
|
0.50
|
|
|
|
10
Years
|
|
Exercised
|
|
|
—
|
|
|
|
|
|
|
|
|
|
Forfeited/Canceled
|
|
|
—
|
|
|
|
|
|
|
|
|
|
Outstanding at September 30, 2017
|
|
|
550,003
|
|
|
$
|
0.50
|
|
|
|
10
Years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vested at September 30, 2017
|
|
|
441,668
|
|
|
$
|
0.50
|
|
|
|
10
Years
|
|
Exercisable at September 30, 2017
|
|
|
441,668
|
|
|
$
|
0.50
|
|
|
|
10
Years
|
|
NOTE
5: STOCK BASED COMPENSATION (CONTINUED)
For
the nine months ended September 30, 2017, the Company estimated the fair value of each stock option on the date of grant using
the Black Scholes valuation model with the following assumptions:
Valuation Assumptions
|
|
|
Risk-free interest rate
|
|
2.14% – 2.31%
|
Expected
dividend yield
|
|
0%
|
Expected stock price
volatility
|
|
100%
|
Expected life of stock
options (in years)
|
|
6.5 to 10
|
NOTE
6: OPERATING LEASES
On
January 15, 2017, the Company entered an agreement with Pueblo, CO Board of Water Works to lease water for the Company’s
cultivation process. The agreement went into effect as of November 1, 2016 with a term of 10 years expiring on October 31, 2026,
with an option to extend the lease upon expiration for 10 additional years. This agreement replaced previously entered agreements
with Pueblo, CO Board of Water Works. The lease requires annual non-refundable minimum service fees of $15,000 and a usage charge
of $1,063 per acre for 30 acres. The minimum service fees and usage charges are subject to escalators for each year based upon
percentage increases of Pueblo, CO Board of Water Works rates from the previous calendar year. Total water lease expense was $11,724
and $18,693 for the three month periods and $35,172 and $47,587 for the nine month periods ended September 30, 2017 and 2016,
respectively.
On
July 12, 2016, the Company entered an agreement to lease office space for a sales office for a term of 15 months expiring on October
31, 2017. The agreement requires monthly lease payments of $4,078 and included three free months of rent forgiven.
On
November 9, 2016, the Company entered an agreement to lease office space for a sales office for a term of 7 months expiring on
May 31, 2017. The lease required monthly lease payments of $704 and was not renewed.
As
of September 30, 2017, minimum rental commitments under the operating leases are as follows:
2017
|
|
$
|
22,267
|
2018
|
|
|
27,756
|
2019
|
|
|
27,756
|
2020
|
|
|
27,756
|
2021
|
|
|
27,756
|
Thereafter
|
|
|
76,654
|
|
|
$
|
209,945
|
NOTE
7: RELATED PARTY
The
Company entered into various note payables with stockholders of the company between March 2017 and September 2017. The notes bear
interest between 2.00% and 3.00% per annum. Principal and interest is payable in one installment due upon the earlier of 120 days
after the Company consummating a reverse merger or nine months after the date of the note. The balances due on these notes is
$1,030,080 as of September 30, 2017.
NOTE
8: COMMON STOCK
See
Note 1 regarding shares issued in reverse merger.
On
September 27, 2017 the Company issued 340,000 shares for proceeds of $150,030.
See
note 10 regarding the stock split.
NOTE
9: SUPPLEMENTAL CASHFLOW DISCLOSURE
The
Company paid interest of $0 and $7,203 for the three month periods and $8,205 and $19,987 during the nine month periods ended
September 30, 2017 and 2016, respectively.
The
Company paid no income taxes during the three month periods ended September 30, 2017 and 2016.
In
February 2017, the Company distributed land held for investment of $69,000 and the related mortgage note payable with a balance
of $53,603 to one of the members.
NOTE
10: SUBSEQUENT EVENTS
On
November 9, 2017, Financial Industry Regulatory Authority authorized a 6-for-1 forward split of the Company’s issued and
outstanding shares of common stock in the form of a stock dividend. Accordingly, shareholders of the Company as of the record
date of November 9, 2017 received five additional shares of common stock for each share then held. All relevant information relating
to number of shares and per share information have been retrospectively adjusted to reflect the split for all periods presented.
On
November 27, 2017 the Company issued 565,000 shares of common stock proceeds of $279,000.
|
Item 2.
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations.
|
Unless the context otherwise requires,
references in this report to “
the Company
,” “
SanSal Wellness
,” “
we
,” “
us
”
and “
our
” refer to SanSal Wellness Holdings, Inc. f/k/a Armeau Brands Inc. and its subsidiary, 271 Lake Davis
Holdings, LLC, a Delaware limited liability company d/b/a/ SanSal Wellness (“
SanSal
”). All share and per share
information in this Report gives pro forma effect to the implementation of a six for one forward stock split effective November
9, 2017.
Forward-Looking Statements
Certain statements made in this report
are “
forward-looking statements
” regarding the plans and objectives of management for future operations. Such
statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements
to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements.
The forward-looking statements included herein are based on current expectations that involve numerous risks and uncertainties.
Our plans and objectives are based, in part, on assumptions involving judgments with respect to, among other things, future economic,
competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately
and many of which are beyond our control. Although we believe that our assumptions underlying the forward-looking statements are
reasonable, any of the assumptions could prove inaccurate and, therefore, there can be no assurance that the forward-looking statements
included in this report will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements
included herein particularly in view of the current state of our operations, the inclusion of such information should not be regarded
as a statement by us or any other person that our objectives and plans will be achieved. We undertake no obligation to revise or
update publicly any forward-looking statements for any reason.
Corporate History
Our company was incorporated in the State
of Nevada on March 15, 2011 under the name “
Armeau Brands Inc.
” The Company’s original business objective
was to produce and market its own brand of ice wine made from grapes harvested in Armenia. While the Company took numerous steps
with respect to implementation of its business plan, including securing sources of production and did, in fact produce 4,500 bottles
of ice wine for product sampling and customer marketing purposes, the Company was unable to raise sufficient capital to fully implement
its business plan and generate revenues.
On June 5, 2017, Mr. Jaitegh Singh purchased
a total of 45,000,000 “
restricted
” shares of our Company’s common stock from our then sole officer and
director, Cassandra Tavukciyan, for aggregate consideration of $345,000. The share purchase was consummated in a private transaction
pursuant to a common stock purchase agreement entered into between Mr. Singh and Ms. Tavukciyan.
Concurrent with the share purchase transaction,
Cassandra Tavukciyan resigned as our Chief Executive Officer, Chief Financial Officer and sole director, and was succeeded in those
capacities by Jaitegh Singh. Mr. Singh relocated the Company’s principal offices to Fort Lauderdale, Florida.
On September 27, 2017 (“
Closing
”),
the Company entered into a Securities Exchange Agreement (the “
Exchange Agreement
”) with all the members of
SanSal (the “
Members
”), pursuant to which SanSal became a wholly-owned subsidiary of the Company (the “
SanSal
Acquisition
”). SanSal, founded in 2015, is a vertically-integrated agribusiness focused on producing full spectrum natural
phytocannabinoid-rich industrial hemp extracts.
Pursuant to the Exchange Agreement, we
acquired all the outstanding limited liability company interests of SanSal in exchange for the issuance to SanSal’s members,
pro rata
, of 46,800,000 “
restricted
” shares of our common stock, whereupon Jaitegh Singh, the holder
of the Company’s currently outstanding 45,000,000 “
restricted
” shares of common stock contributed those
shares to the capital of the Company for cancellation.
At Closing, Alexander M. Salgado and Erduis
Sanabria, the members of SanSal’s management team, were appointed to the Company’s board of directors and as the Company’s
Chief Executive Officer and Executive Vice President, respectively. Jaitegh Singh, who was then the Company’s President and
sole director, then stepped down from such position, but assumed the position of the company’s Vice President and Secretary.
In addition, at Closing, former SanSal
Members, holding an aggregate of 26,674,500 shares of our common stock, including Messrs. Salgado and Sanabria, entered into a
five-year voting agreement, pursuant to which Messrs. Salgado and Erduis have the right to direct the voting of their shares on
all matter presented to shareholders for a vote.
Following completion of the SanSal Acquisition,
the Company determined to focus its business on the business of SanSal as it offered, in the opinion of management, far greater
opportunities for growth and increase in shareholder value. Accordingly, we applied to FINRA to (a) change our corporate name from
“
Armeau Brands Inc.
” to “
SanSal Wellness Holdings, Inc.
” (with a comparable change in our
trading symbol from ARUU to SSWH); (b) authorize a class of “
blank check
” preferred stock; and (c) implement
a six-for-one forward stock split. The name, trading symbol and authorized capitalization changes became effective as of November
7, 2017 and the stock split was implemented on November 9, 2017.
As a result of the completion of the SanSal
Acquisition and management’s determination to focus the Company’s future business efforts on SanSal’s business,
SanSal is deemed to be the survivor of the SanSal Acquisition for financial statement purposes. Moreover, we have changed the Company’s
fiscal year-end from January 31 to December 31 to coincide with SanSal’s fiscal year-end, effective with the year ending
December 31, 2017 and accordingly, the Company is filing this report to ensure that there is no gap in financial reporting.
Business Overview
SanSal Wellness owns and operates a 140-acre
farm in Pueblo, Colorado, capable of producing over 200,000 proprietary full spectrum phytocannabinoid-rich hemp plants yielding
a potential minimum annual harvest of over 200,000 pounds of outdoor-grown industrial hemp (less than 0.3% THC). The Company also
operates approximately 15,000 sq. ft. of climate-controlled greenhouses to produce a consistent supply of year-round indoor-cultivated
hemp. In addition, there is a 10,000-sq. ft. onsite facility used for processing raw industrial hemp, oil extraction, formulation
laboratories, and quality/purity testing. SanSal Wellness is registered with the Colorado Department of Agriculture to grow industrial
hemp pursuant to federal law.
SanSal Wellness meticulously processes
its hemp crop to produce vastly superior quality whole-plant hemp oil, extracts and derivatives which contain the entire broad
spectrum of cannabinoids extracted from the flowers and leaves of hemp plants. Whole-plant hemp oil is known to provide the essential
phytocannabinoid “entourage effect” resulting from the synergistic absorption of the entire broad spectrum of unique
hemp cannabinoids by the receptors of the human endocannabinoid system. Most commercially available hemp oil and extracts are not
derived from the entire plant and are usually from less desired hemp seed which contain fewer cannabinoids. As a result, SanSal
Wellness believes that its products are premier quality cannabinoids and are highly sought after by consumers and manufacturers
of premium hemp products.
SanSal Wellness has developed a wide variety
of formulated phytocannabinoid-rich hemp products available in bulk, white label, and private label custom formulations for distributors
and retailers. These types of products are in extremely high demand by health food markets, wellness centers, physicians and other
healthcare practitioners. Primary B2B targets are the wholesale bulk hemp oil arena, cosmetics, food and beverage industries, and
the pharmaceutical industry.
SanSal Wellness products (20+ SKUs) include
vegan capsules, tinctures, formulations for sublingual applications and infused edibles, lotions, salves, vape oils and pre-filled
vape cartridges, and oral syringes. Many of the Company’s whole-plant hemp oil products and formulations are available for
purchase direct from SanSal Wellness and through numerous online and retail outlets.
Corporate Information
The Company was incorporated in the state
of Nevada on March 15, 2011 under the name “
Armeau Brands Inc.
” and changed its name to “
SanSal Wellness
Holdings, Inc.
” effective November 7, 2017.
Our executive offices are located at 6610
North University Drive #220, Fort Lauderdale, FL 33321 and our telephone number is (954) 722-1300. Our corporate website is
www.sansalwellness.com
.
Information appearing on our corporate website is not part of this report.
Results of Operations
Three months ended September 30, 2017
compared to three months ended September 30, 2016
We had net sales for the three months ended
September 30, 2017 of $255,444, as compared to $-0- for the three months ended September 30, 2016, giving effect to the commencement
of commercial production and sale of SanSal Wellness’ hemp extract products in 2017. Reflecting the foregoing, cost of sales
was $116,726 in the 2017 quarter, as compared to $-0- in the 2016 quarter, which resulted in gross profit of $138,718 in the 2017
quarter, as compared to $-0- in the 2016 quarter.
Selling, general and administrative expenses
decreased to $279,443 for the three months ended September 30, 2017, from $457,801 for the three months ended September 30, 2016,
as a result of a decline in start-up costs incurred in the 2016 quarter. During the 2017 quarter, we incurred merger expenses of
$260,750 related to the SanSal Acquisition and our becoming a public company, as compared to $-0- in the 2016 quarter.
Interest expense for the three months
ended September 30, 2017 was $11,892, reflecting increased outstanding debt, $6,092 of which was attributable to loans from
principal stockholders, as compared to $-0- for the three months ended September 30, 2016.
As a result of our generating
revenues from sales offset by cost of good soled during the three months ended September 30, 2017 and the decline in
operating expenses from the 2017quarter to the 2016 quarter, offset by the merger expenses we incurred in the 2017 quarter,
net loss for the 2017 quarter declined to $413,367 or $0.01 per share based on 58,567,253 weighted average shares outstanding
from $457,801 or $0.01 per share based on 58,500,000 weighted average shares outstanding for the 2016 quarter.
Nine months ended September 30, 2017
compared to nine months ended September 30, 2016
We had net sales for the nine months ended
September 30, 2017 of $755,749, as compared to $11,773 for the nine months ended September 30, 2016, giving effect to the commencement
of commercial production and sale of SanSal Wellness’ hemp extract products in the 2017 period, as opposed to only limited
trial marketing having taken place in 2016. Reflecting the foregoing, cost of sales was $367,328 in the 2017 period, as compared
to $9,500 in the 2016 period, which resulted in gross profit of $388,421 for the nine months ended September 30, 2017, as compared
to $2,273 for the nine months ended September 30, 2016.
Selling, general and administrative expenses
increased substantially to $1,070,637 for the nine months ended September 30, 2017, from $749,453 for the nine months ended September
30, 2016, reflecting SanSal Wellness’ increased level of operations during the 2017 period. During the 2017 period, we incurred
merger expenses of $260,750 related to the SanSal Acquisition and our becoming a public company, as compared to $-0- in the 2016
quarter.
Interest expense for the nine months
ended September 30, 2017 was $30,753, reflecting increased outstanding debt, $9,716 of which was attributable to loans from principal stockholders, as compared to
$-0- for the nine months ended September 30, 2016.
As a result of the increase in
operating expenses for and the merger expenses incurred during the nine months ended September 30, 2017, offset by revenues
in sales less cost of goods sold in the 2017 period, net loss for the nine months ended September 30 2017, increased to
$973,719 or $0.02 per share based on 58,522,500 weighted average shares outstanding from $747,180 or $0.01 per share based on
58,500,000 weighted average shares outstanding for the 2016 quarter.
Liquidity and Capital Resources
As of September 30, 2017, total assets
were $6,147,924, as compared to $5,037,068 on December 31, 2016, with the increase in large part resulting from an increase in
inventories to $1,587,271 at September 30, 2017, from $659,048 at December 31, 2016, as the Company produced extract products from
its initial hemp harvest.
Total current liabilities as of September
30, 2017, were $1,812,431, as compared to $411,184 at December 31, 2016. The increase in the foregoing was in large part due to
the issuance during the nine months ended September 39, 2017 of $1,030,080 in principal amount of notes to Alexander Salgado and
Erduis Sanabria, principal stockholders, directors and executive officers of the Company to evidence working capital loans made
by them to the Company (the “
Shareholder Notes
”). Interest on the Shareholder Notes accrues at rates of between
2% and 3% per annum and is payable, together with the principal amount of the Shareholder Notes at maturity, which is the earlier
to occur of 120 days after closing of the SanSal Acquisition or nine months from the respective dates of the shareholder Notes.
Net cash used in operating activities declined
slightly to $1,327,622 for the nine months ended September 30, 2017, as compared to $1,372,620 for the same period in 2016.
Net cash used in investing activities declined
to $373,887 for the nine months ended September 30, 2017, from $2,430,438 for the 2016 period, reflecting a significant decrease
in cash used for the purchase of property and equipment and capital leases from the 2016 period to the 2017 period.
Net cash provided by financing activities
in the 2017 period was $1,701,173 reflecting in large part the proceeds from the issuance of the Shareholder Notes and private
offerings of equity in the Company during the period, as compared to $3,621,724 in the 2016 period, reflecting in large part the
receipt of proceeds of private offerings of equity in the Company during the period.
Our primary sources of capital to develop
and implement our business plan was been from private offerings of our equity securities and the loans from shareholders evidenced
by the Shareholder Notes.
The Company believes that it will require
additional financing to achieve profitability. The Company intends to seek such financing through additional private offerings
of its common stock. The Company does not intend to accept any further loans from shareholders. Further, our independent auditors
report for the year ended December 31, 2016 includes an explanatory paragraph strategy that our lack of revenues and working capital
raise substantial doubt about our ability to continue a growing concern. While we believe additional financing will be available
to us, there can be no assurance that equity financing will be available on commercially reasonable terms or otherwise, when needed.
Moreover, any such additional financing may dilute the interests of existing shareholders. The absence of additional financing,
when needed, could substantially harm the Company, its business, results of operations and financial condition.